A detailed history of Boone Capital Management LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Boone Capital Management LLC holds 523,679 shares of MIRM stock, worth $21.2 Million. This represents 4.67% of its overall portfolio holdings.

Number of Shares
523,679
Previous 451,898 15.88%
Holding current value
$21.2 Million
Previous $11.4 Billion 57.73%
% of portfolio
4.67%
Previous 2.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$23.57 - $34.85 $1.69 Million - $2.5 Million
71,781 Added 15.88%
523,679 $17.9 Billion
Q1 2024

May 15, 2024

SELL
$24.92 - $30.02 $952,965 - $1.15 Million
-38,241 Reduced 7.8%
451,898 $11.4 Billion
Q4 2023

Feb 14, 2024

BUY
$27.14 - $34.93 $2.72 Million - $3.51 Million
100,348 Added 25.74%
490,139 $14.5 Billion
Q3 2023

Nov 14, 2023

BUY
$24.63 - $32.85 $9.6 Million - $12.8 Million
389,791 New
389,791 $12.3 Billion

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.48B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Boone Capital Management LLC Portfolio

Follow Boone Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boone Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boone Capital Management LLC with notifications on news.